ORCL vs UNCY · P/E 31, rev $67.36B vs $195.0M cap
Oracle Corporation (ORCL) versus Unicycive Therapeutics Inc (UNCY) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
Unicycive Therapeutics Inc (UNCY) is a biotechnology company listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
UNCY does not have a complete income-statement cache yet.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. UNCY currently screens at market cap $195.0M.
Not investment advice. Open the ORCL and UNCY stock pages for the full models.
Not investment advice.